Cargando…
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer
OBJECTIVE: HER2 overexpression is associated with aggressive phenotypes in breast cancer, including increased tumor proliferation, greater invasiveness, and reduced overall survival. The overall response rate to HER2-targeted therapies remains <30%. There is an urgent need for the identification...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367898/ https://www.ncbi.nlm.nih.gov/pubmed/28356761 http://dx.doi.org/10.2147/OTT.S132806 |